PUBLIC CONTRACT · 2020
Aquisição de VEDOLizumab 300 mg Pó conc sol inj Fr IV, para o Hospital Divino Espírito Santo de Ponta Delgada, EPER
- Contract value
- €96,712.56
- Signed on
- 25 May 2020
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6725308PUBLISHED SUBJECT
Aquisição de VEDOLizumab 300 mg Pó conc sol inj Fr IV, para o Hospital Divino Espírito Santo de Ponta Delgada, EPER
Parties involved
- Place of performance
- Portugal, Região Autónoma dos Açores
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- TAKEDA FARMACÊUTICA PORTUGAL, LDA · Tax ID 502801204
Values and timeline
- Contract price
- €96,712.56
- Procedure base price
- €110,528.64
- Total effective price
- Not reported on Portal BASE
- Publication date
- 29 June 2020
- Award date
- 6 May 2020
- Signing date
- 25 May 2020
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos e DLR no 27/2015/A, de 29.12
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4461732
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.